Ruboxistaurin a reality for reduced vision loss in diabetic retinopathy

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Clinical safety of the selective PKC-&bgr; inhibitor, ruboxistaurin

By McGill Janet B   King George L   Berg Paul H   Price Karen L   Kles Keri A   Bastyr Edward J   Hyslop David L  

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 835-845

Informa Healthcare

Access to resources Recommend Favorite

Ruboxistaurin: PKC-β inhibition for complications of diabetes

By Danis Ronald P   Sheetz Matthew J  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2913-2925

Informa Healthcare

Access to resources Recommend Favorite

Ruboxistaurin provides hope in diabetic peripheral neuropathy

By  

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Ruboxistaurin: reduced progression of diabetic retinopathy?

By  

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite